Non-invasive measurement of hemoglobin: assessment of two different point-of-care technologies
Etienne Gayat, Jérôme Aulagnier, Emmanuel Matthieu, Mireille Boisson, Marc Fischler, Etienne Gayat, Jérôme Aulagnier, Emmanuel Matthieu, Mireille Boisson, Marc Fischler
Abstract
Background: Measurement of blood hemoglobin (Hb) concentration is a routine procedure. Using a non-invasive point-of-care device reduces pain and discomfort for the patient and allows time saving in patient care. The aims of the present study were to assess the concordance of Hb levels obtained non-invasively with the Pronto-7 monitor (version 2.1.9, Masimo Corporation, Irvine, USA) or with the NBM-200MP monitor (Orsense, Nes Ziona, Israel) and the values obtained from the usual colorimetric method using blood samples and to determine the source of discordance.
Methods and findings: We conducted two consecutive prospective open trials enrolling patients presenting in the emergency department of a university hospital. The first was designed to assess Pronto-7™ and the second NBM-200MP™. In each study, the main outcome measure was the agreement between both methods. Independent factors associated with the bias were determined using multiple linear regression. Three hundred patients were prospectively enrolled in each study. For Pronto-7™, the absolute mean difference was 0.56 g.L(-1) (95% confidence interval [CI] 0.41 to 0.69) with an upper agreement limit at 2.94 g.L(-1) (95% CI [2.70;3.19]), a lower agreement limit at -1.84 g.L(-1) (95% CI [-2.08;-1.58]) and an intra-class correlation coefficient at 0.80 (95% CI [0.74;0.84]). The corresponding values for the NBM-200MP™ were 0.21 [0.02;0.39], 3.42 [3.10;3.74], -3.01 [-3.32;-2.69] and 0.69 [0.62;0.75]. Multivariate analysis showed that age and laboratory values of hemoglobin were independently associated with the bias when using Pronto-7™, while perfusion index and laboratory value of hemoglobin were independently associated with the bias when using NBM-200MP™.
Conclusion: Despite a relatively limited bias in both cases, the large limits of agreement found in both cases render the clinical usefulness of such devices debatable. For both devices, the bias is independently and inversely associated with the true value of hemoglobin.
Trial registration: ClinicalTrials.gov NCT01321580 and NCT01321593.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Severinghaus JW, Astrup PB. History of blood gas analysis. VI. Oximetry. J Clin Monit. 1986;2:270–288.
- Report of the WHO/UNICEF/UNU Consultation. Geneva, Switzerland: WHO (World Health Organization); 1994. Indicators and Strategies for Iron Deficiency and Anemia Programmes.
- Khusun H, Yip R, Schultink W, Dillon DH. World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. J Nutr. 1999;129:1669–1674.
- Gayat E, Bodin A, Sportiello C, Boisson M, Dreyfus JF, et al. Performance Evaluation of a Noninvasive Hemoglobin Monitoring Device. Ann Emerg Med. 2011.
- Hahn RG, Li Y, Zdolsek J. Non-invasive monitoring of blood haemoglobin for analysis of fluid volume kinetics. Acta Anaesthesiol Scand. 2010;54:1233–1240.
- Macknet MR, Allard M, Applegate RL, 2nd, Rook J. The accuracy of noninvasive and continuous total hemoglobin measurement by pulse CO-Oximetry in human subjects undergoing hemodilution. Anesth Analg. 2010;111:1424–1426.
- Miller RD, Ward TA, Shiboski SC, Cohen NH. A comparison of three methods of hemoglobin monitoring in patients undergoing spine surgery. Anesth Analg. 2011;112:858–863.
- Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Bmj. 2003;326:41–44.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310.
- Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59:491–500.
- Shoukri MM, Asyali MH, Donner A. Sample size requirements for the design of reliability study: review and new results. Statistical Methods in Medical Research. 2004;13:251–271.
- von Schenck H, Falkensson M, Lundberg B. Evaluation of “HemoCue,” a new device for determining hemoglobin. Clin Chem. 1986;32:526–529.
- Gayat E, Bodin A, Fischler M. Instability in non-invasive haemoglobin measurement: a possible influence of oxygen administration. Acta Anaesthesiol Scand. 2011.
- Gehring H, Hornberger C, Dibbelt L, Rothsigkeit A, Gerlach K, et al. Accuracy of point-of-care-testing (POCT) for determining hemoglobin concentrations. Acta Anaesthesiol Scand. 2002;46:980–986.
- Lardi AM, Hirst C, Mortimer AJ, McCollum CN. Evaluation of the HemoCue for measuring intra-operative haemoglobin concentrations: a comparison with the Coulter Max-M. Anaesthesia. 1998;53:349–352.
Source: PubMed